AIDS Treatment News logo      

August 27, 2009

Risk of kidney problems similar for tenofovir and alternative drugs

"Treatment with tenofovir does not involve a greater risk of kidney problems compared to alternative NRTI drugs, US investigators report in the online edition of AIDS. They found that regardless of whether a patient took tenofovir or an alterative drug as part of their initial antiretroviral therapy, there was a modest decline in kidney function, but that this soon stabilised. However, the research did show that taking tenofovir in combination with a ritonavir-boosted protease inhibitor could have an adverse effect on the health of the kidneys."

Read more in Aidsmap, August 25, 2009.